241 related articles for article (PubMed ID: 31216997)
41. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
42. KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis.
Hou J; Huang H; Xie J; Yu W; Hao H; Li H
Mol Carcinog; 2024 Feb; 63(2):286-300. PubMed ID: 37888201
[TBL] [Abstract][Full Text] [Related]
43. ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
Chen S; Gao Y; Chen F; Wang TB
Urol Int; 2023; 107(3):310-320. PubMed ID: 35504258
[TBL] [Abstract][Full Text] [Related]
44. DNA topoisomerase II alpha promotes the metastatic characteristics of glioma cells by transcriptionally activating β-catenin.
Liu Y; Ma J; Song JS; Zhou HY; Li JH; Luo C; Geng X; Zhao HX
Bioengineered; 2022 Feb; 13(2):2207-2216. PubMed ID: 35012441
[TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
[TBL] [Abstract][Full Text] [Related]
46. The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells.
Song J; Ma Q; Hu M; Qian D; Wang B; He N
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544723
[TBL] [Abstract][Full Text] [Related]
47. TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.
Jain M; Zhang L; He M; Zhang YQ; Shen M; Kebebew E
Endocr Relat Cancer; 2013 Jun; 20(3):361-70. PubMed ID: 23533247
[TBL] [Abstract][Full Text] [Related]
48. Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma.
Zhou G; Qin G; Zhang Z; Zhao H; Xue L
Front Immunol; 2023; 14():1283792. PubMed ID: 37954600
[TBL] [Abstract][Full Text] [Related]
49. TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
Chen Z; He S; Zhan Y; He A; Fang D; Gong Y; Li X; Zhou L
EBioMedicine; 2019 Sep; 47():208-220. PubMed ID: 31420300
[TBL] [Abstract][Full Text] [Related]
50. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer.
de Resende MF; Vieira S; Chinen LT; Chiappelli F; da Fonseca FP; Guimarães GC; Soares FA; Neves I; Pagotty S; Pellionisz PA; Barkhordarian A; Brant X; Rocha RM
J Transl Med; 2013 Feb; 11():36. PubMed ID: 23398928
[TBL] [Abstract][Full Text] [Related]
51. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
[TBL] [Abstract][Full Text] [Related]
52. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
[TBL] [Abstract][Full Text] [Related]
53. Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
[TBL] [Abstract][Full Text] [Related]
54. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W
Hereditas; 2019; 156():24. PubMed ID: 31333338
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the Small Heat Shock Protein Family Members
Gianniou DD; Sklirou AD; Papadimitriou MA; Pilala KM; Stravodimos K; Avgeris M; Scorilas A; Trougakos IP
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768927
[TBL] [Abstract][Full Text] [Related]
56. TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.
Labbé DP; Sweeney CJ; Brown M; Galbo P; Rosario S; Wadosky KM; Ku SY; Sjöström M; Alshalalfa M; Erho N; Davicioni E; Karnes RJ; Schaeffer EM; Jenkins RB; Den RB; Ross AE; Bowden M; Huang Y; Gray KP; Feng FY; Spratt DE; Goodrich DW; Eng KH; Ellis L
Clin Cancer Res; 2017 Nov; 23(22):7072-7083. PubMed ID: 28899973
[No Abstract] [Full Text] [Related]
57. Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/β-catenin signaling pathway.
Han CT; Bao QY; Cheng SJ; Liu M; Qian HN; Li D
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1081-1087. PubMed ID: 32096177
[TBL] [Abstract][Full Text] [Related]
58. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
[TBL] [Abstract][Full Text] [Related]
59. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
60. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B
J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
